Drawing for HYPROXCYN

USPTO serial 87227002

HYPROXCYN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BIBB, SCOTT
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HYPROXCYN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gregory B. Phillips

Gregory B. Phillips Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorIrvine, CA 92614UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Personal lubricants, medicated moisturizers, pharmaceutical products, pharmaceutical preparations, microbicides and drugs for medical purposes for treatment and prevention of sexually transmitted infections, viral, fungal and bacterial disease, namely, bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), human immunodeficiency virus (HIV), gonorrhea and syphilis; chemical and biological preparations, substances for treatment and prevention of bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS); reagents for medical purposes; pharmaceutical preparations containing polyvalent compounds, synthetic molecules and dendrimers for medical purposes for treatment and prevention of bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS); antimicrobial preparations, namely, microbicidial preparations in the nature of gels, foams, creams, films, solutions, suppositories, suspensions and lotions for vaginal, rectal and transdermal use for treatment and prevention of bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS)ACTIVE—
010Contraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devices treated with personal lubricants, moisturizers, pharmaceuticals, pharmaceutical preparations, microbicides and drugs for medical purposes for treatment and prevention of sexually transmitted infections, viral, fungal and bacterial disease, namely, bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), human immunodeficiency virus (HIV), gonorrhea and syphilisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 25, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 25, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 30, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 27, 2020EX5GSOU EXTENSION 5 GRANTED—
Jun 25, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 9, 2020EXT5SOU EXTENSION 5 FILED—
Jun 9, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 11, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 9, 2019EX4GSOU EXTENSION 4 GRANTED—
Dec 9, 2019EXT4SOU EXTENSION 4 FILED—
Dec 9, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 18, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 14, 2019EX3GSOU EXTENSION 3 GRANTED—
Jun 14, 2019EXT3SOU EXTENSION 3 FILED—
Jun 14, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 6, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 15, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 13, 2018EX2GSOU EXTENSION 2 GRANTED—
Dec 13, 2018EXT2SOU EXTENSION 2 FILED—
Dec 13, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 25, 2018ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 20, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 18, 2018EX1GSOU EXTENSION 1 GRANTED—
Jun 18, 2018EXT1SOU EXTENSION 1 FILED—
Jun 18, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 19, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 24, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 24, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 14, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 10, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 9, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 9, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 23, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 23, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 11, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2017DOCKASSIGNED TO EXAMINER—
Nov 8, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 8, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance